跳至主要内容
临床试验/NCT00213928
NCT00213928已完成2 期

A Single-blind, Randomized Trial of Horse Chestnut Seed Extract for the Treatment of Lymphedema of the Arm in Breast Cancer Survivors

University of Wisconsin, Madison1 个研究点 分布在 1 个国家目标入组 56 人开始时间: 2002年5月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
已完成
入组人数
56
试验地点
1
主要终点
Reduction of arm lymphedema

研究概览

简要总结

To help Treat Lymphedema of the Arm in Breast Cancer Survivors with Horse chestnut Seed Extract

详细描述

The objectives of this study are to evaluate the effectiveness of escin (as horse chestnut seed extract) for arm lymphedema in women following treatment for breast cancer, to evaluate the accuracy and sensitivity of bioelectric impedance as a measurement of lymphedema of the arm, and to validate the proposed arm lymphedema quality-of-life questionnaire.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Factorial
主要目的
Supportive Care
盲法
Single (Participant)

入排标准

年龄范围
17 Years 至 —(Child, Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Patient demonstrates unilateral (ipsilateral to breast cancer resection side) lymphedema of the upper extremity. An extravascular water ratio of ³1.1/1 between the affected vs normal arm using multiple-frequency bioelectric impedance will be used as a criterion for lymphedema. There is not upper limit to the extent of arm volume (lymphedema)
  • Patient is greater than 6 months from last surgical and/or radiation treatment to the affected axilla.

排除标准

  • Patients may not be receiving or be scheduled to receive cytotoxic or radiation chemotherapy treatment while on this lymphedema study (Last chemotherapy > 4 weeks prior). Women who are being treated adjuvantly with tamoxifen, raloxifene, or an aromatase inhibitor remain eligible
  • Patients with a history of recurrent (more than 1 episode) arm cellulitis, prior or existing venous clot, or considered to have "woody" fibrosis of the affected arm are not eligible. Antibiotics used to treat any prior episode of cellulitis must have be completed no more recently than 3 months prior to initial screening.

研究组 & 干预措施

Horse Chestnut Seed Extract

Active Comparator

Horse chestnut seed extract (escins, aesins)

干预措施: Horse Chestnut Seed Extract (Drug)

结局指标

主要结局

Reduction of arm lymphedema

次要结局

  • - validation of lymphedema questionnaire
  • - comparison of bioelectric impedance to measure lymphedema changes
  • - validation of bioelectric impedance to measure lymphedema changes

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验